Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding
Niche
1 other identifier
interventional
95
0 countries
N/A
Brief Summary
Prevalence of Cesarean Section Niche in women With Unexplained Abnormal Uterine Bleeding
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2017
CompletedFirst Submitted
Initial submission to the registry
April 22, 2017
CompletedFirst Posted
Study publicly available on registry
April 26, 2017
CompletedApril 26, 2017
April 1, 2017
1.3 years
April 22, 2017
April 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of cisarean section niche
Prevalence of cisarean section niche in women complainig of unexplained abnormal uterine bleeding
1 year
Study Arms (1)
Office hysteroscopy
OTHERExaminatin with Office hysteroscope for women with abnormal uterine bleeding who had a history of previous cesarean section
Interventions
Diagnosis of C.S niche in patients wit AUB by office hysteroscope
Eligibility Criteria
You may qualify if:
- Patients with a history of cesarean section who are complaining of abnormal uterine bleeding with the following criteria :
- Normal complete blood count apart from paramaters of anemia
- Not using drugs affecting coagulation profile
- Bleeding is not related to pregnancy
- Not using intrauterine contraceptive devices or hormonal contraceptives
- By ultrasonography : no abnormalities in the pelvis e.g benign or malignant tumors , ovarian cysts or tumors
- No evidence of cervical abnormalities as cause of bleeding with cervical examination or cervical smears
You may not qualify if:
- If the patient refused the technique ( office hysteroscopy )
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Early Cancer Detection Unit
Study Record Dates
First Submitted
April 22, 2017
First Posted
April 26, 2017
Study Start
January 1, 2016
Primary Completion
April 20, 2017
Study Completion
April 20, 2017
Last Updated
April 26, 2017
Record last verified: 2017-04